India

10 Vaccines Approved for Use in India

Protein Subunit

Serum Institute of India

COVOVAX (Novavax formulation)

Approved in 5 countries
3 trials in 1 country
Approval Source: timesofindia.indiatimes.com
Protein Subunit

Biological E Limited

Corbevax

Approved in 2 countries
7 trials in 1 country
Approval Source: bbc.com
DNA

Zydus Cadila

ZyCoV-D

Approved in 1 country
5 trials in 1 country
Approval Source: reuters.com
RNA

Moderna

Spikevax

Approved in 86 countries
67 trials in 23 countries
Approval Source: france24.com
Non Replicating Viral Vector

Gamaleya

Sputnik Light

Approved in 26 countries
7 trials in 3 countries
Approval Source: hindustantimes.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Approval Source: pib.gov.in
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Approval Source: nytimes.com
Non Replicating Viral Vector

Serum Institute of India

Covishield (Oxford/ AstraZeneca formulation)

Approved in 49 countries
4 trials in 1 country
Approval Source: cdsco.gov.in
Inactivated

Bharat Biotech

Covaxin

Approved in 14 countries
14 trials in 2 countries
Approval Source: bbc.com

16 in Clinical Trials in India

Protein Subunit

Biological E Limited

Corbevax

Approved in 2 countries
7 trials in 1 country
Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
16 trials in 12 countries
Protein Subunit

Serum Institute of India

COVOVAX (Novavax formulation)

Approved in 5 countries
3 trials in 1 country
Protein Subunit

University Medical Center Groningen

AKS-452

4 trials in 2 countries
DNA

Zydus Cadila

ZyCoV-D

Approved in 1 country
5 trials in 1 country
Non Replicating Viral Vector

Bharat Biotech

BBV154

2 trials in 1 country
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Non Replicating Viral Vector

Serum Institute of India

Covishield (Oxford/ AstraZeneca formulation)

Approved in 49 countries
4 trials in 1 country
Inactivated

Bharat Biotech

Covaxin

Approved in 14 countries
14 trials in 2 countries
Protein Subunit

Biological E Limited

BECOV2B

2 trials in 1 country
Protein Subunit

Biological E Limited

BECOV2C

2 trials in 1 country
Protein Subunit

Biological E Limited

BECOV2D

2 trials in 1 country
RNA

Gennova Biopharmaceuticals Limited

HGCO19

2 trials in 1 country
RNA

Gennova Biopharmaceuticals Limited

GEMCOVAC-19

2 trials in 1 country
Non Replicating Viral Vector

Gamaleya

Sputnik Light

Approved in 26 countries
7 trials in 3 countries